Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lamotrigine clearance during pregnancy.

T A Tran1, I E Leppik, K Blesi

  • 1MINCEP Epilepsy Care, University of Minnesota, Minneapolis, MN 55416, USA.

Neurology
|July 24, 2002
PubMed
Summary

Pregnancy significantly increases lamotrigine (LTG) clearance, requiring higher doses during gestation. Clearance returns to baseline postpartum, necessitating LTG dose reduction. Monitoring is crucial throughout pregnancy and after delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydropower reservoirs - their potential association with transmission of trematodes in Vietnam.

Journal of helminthology·2025
Same author

Investigating the magnetic and magnetocaloric behaviors of LiSm(PO<sub>3</sub>)<sub>4</sub>.

RSC advances·2023
Same author

<sup>135</sup>La as an Auger-electron emitter for targeted internal radiotherapy.

Physics in medicine and biology·2017
Same author

[Hypercalcemia revealing sarcoidosis in a child].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2016
Same author

Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2.

EJNMMI research·2016
Same author

Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.

Chemical communications (Cambridge, England)·2015

Area of Science:

  • Pharmacokinetics and pharmacodynamics
  • Maternal-fetal medicine
  • Epilepsy management

Background:

  • Lamotrigine (LTG) is a widely used antiepileptic drug.
  • Pregnancy is known to alter drug pharmacokinetics, including clearance.
  • Understanding LTG clearance changes during pregnancy is vital for effective treatment.

Purpose of the Study:

  • To quantify changes in lamotrigine (LTG) clearance.
  • To evaluate LTG clearance before, during, and after pregnancy.
  • To inform optimal LTG dosing strategies in pregnant individuals.

Main Methods:

  • Prospective evaluation of 12 pregnancies with complete steady-state LTG data.
  • Calculation of apparent LTG clearance (L/[kg.day]) at preconception, trimesters, and postpartum.

Related Experiment Videos

  • Statistical analysis using ANOVA and Student's t-tests to compare clearance values.

    • Main Results:

    • Apparent LTG clearance increased by over 65% in the second and third trimesters (p < 0.05).
    • Higher LTG doses were needed in 11 pregnancies to maintain therapeutic levels.
    • Clearance decreased postpartum, returning to preconception levels, requiring dose reduction.

    Conclusions:

    • Pregnancy significantly increases lamotrigine (LTG) clearance, exceeding 50%.
    • This pharmacokinetic change occurs early in pregnancy and rapidly reverses postpartum.
    • Continuous monitoring of LTG levels and dose adjustment are essential throughout the pregnancy continuum.